NME3 anticorps
-
- Antigène Voir toutes NME3 Anticorps
- NME3 (NME/NM23 Nucleoside Diphosphate Kinase 3 (NME3))
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NME3 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- non-metastatic cells 3, protein expressed in
- Isotype
- IgG
- Top Product
- Discover our top product NME3 Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 2 mg/mL
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- NME3 (NME/NM23 Nucleoside Diphosphate Kinase 3 (NME3))
- Autre désignation
- NME3 (NME3 Produits)
- Sujet
- Synonyms: Background:Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Probably has a role in normal hematopoiesis by inhibition of granulocyte differentiation and induction of apoptosis.
- Poids moléculaire
- 18 kDa
- ID gène
- 4832
- UniProt
- Q13232
- Pathways
- Nucleotide Phosphorylation, Ribonucleoside Biosynthetic Process
-